[1] Weinberg B A, Marshall J L, Salem M E. The growing challenge of young adults with colorectal cancer[J]. Oncology,2017,31(5):381-389. [2] Gao R, Gao Z, Huang L, et al.Gut microbiota and colorectal cancer[J]. European Journal of Clinical Microbiology and Infectious Diseases,2017,36(5):757-769. [3] Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, et al. Colorectal carcinoma:a general overview and future perspectives in colorectal cancer[J]. International Journal of Molecular Medicine, 2017,18(1):197. [4] Moore J S, Aulet T H. Colorectal cancer screening[J]. Surgical Clinics of North America, 2017,97(3):487-502. [5] Marcuello M, Vymetalkova V, Neves R P L, et al.Circulating biomarkers for early detection and clinical management of colorectal cancer[J]. Molecular Aspects of Medicine, 2019,69:107-122. [6] Osumi H, Shinozaki E, Yamaguchi K, et al. Clinical utility of circulating tumor DNA for colorectal cancer[J].Cancer Science, 2019,110(4):1148-1155. [7] 中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志, 2018,56(4):241-258. [8] 卫生部医政司结直肠癌诊疗规范专家工作组.结直肠癌诊疗规范(20l0年版)[J].中华胃肠外科杂志,2010,13(11):865, 875. [9] 陈如萍, 刘蕊.下一代测序技术在结直肠癌诊疗中的应用[J].天津医药, 2020,48(9):903-907. [10] 黄骏昌, 吴茸, 何立晨, 等.腹腔镜结直肠癌根治术治疗结肠癌患者临床疗效[J].临床军医杂志, 2020,48(9):1081-1082. [11] 傅宇, 徐群.腹腔镜与开腹行结直肠癌根治术治疗早期结直肠癌效果观察[J].中国现代普通外科进展, 2020,23(7):552-553. [12] 付长霞, 王晓琳, 王昭顺, 等.联合检测18F-FDG PET/CT、CEA、CA199在结直肠癌预后评估中的价值[J].中国医药指南, 2020,18(2):130-131. [13] 马文波, 刘胡.PET-CT/MRI融合图像诊断直肠癌淋巴结转移的价值分析[J].中国CT和MRI杂志, 2020,18(3):42-44, 102. [14] 伏红超, 冯赟, 赵宾飞, 等.MRI超薄斜轴位结合DWI对直肠癌系膜内淋巴结转移的诊断价值[J].中国中西医结合影像学杂志, 2020,18(4):396-398. [15] 赵鹏, 肖杨, 迟宝权, 等.定量多参数MRI对直肠癌患者热化疗结果的评估价值[J].中国老年学杂志, 2020,40(2):290-294. [16] 朱慧, 祁荣兴, 邰兆芹, 等.低剂量CT结肠成像联合MRI对结直肠癌的诊断价值[J].现代消化及介入诊疗, 2019,24(2):207-210. [17] 肖栋, 韩拓, 翟超, 等.MRI联合MSCT检查对结直肠癌术前T、N分期诊断价值研究[J].中国CT和MRI杂志, 2020,18(10):135-137. |